NCT05924074View on ClinicalTrials.gov

Ferroptosis Study in SF3B1-mutant Myelodysplastic Syndromes (FerMDS)

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 21, 2025

Primary Completion Date

February 28, 2027

Study Completion Date

February 28, 2027

Conditions
Myelodysplastic SyndromesFerroptosis
Interventions
BIOLOGICAL

Biological sampling

The procedure will consist of an additional bone marrow sample and blood sample

Trial Locations (3)

Unknown

NOT_YET_RECRUITING

CHU de Bordeaux, Laboratoire d'Hématologie, Pessac

NOT_YET_RECRUITING

CHU de Bordeaux, Service de Médecine Interne, Pessac

RECRUITING

CHU de Bordeaux, Service Hématologie Clinique et Thérapie Cellulaire, Pessac

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER